By: Debbie Bickford RDH
October 19, 2018
A Type II Diabetic patient, who has been a long term client, has uncontrolled periodontal disease and a history of not responding to previous periodontal treatment.
Additional comments: Pt declined 3rd script of Metronidazole, Amoxicillin for now. Pt to continue with ProBiora Pro oral probiotics, Immune tabs and Sonicare usage as well as an improved diet and exercise routine. Patient has an appointment with her nephrologist soon and will consult on antibiotic usage. Pt will probably wait for 6 months for her next saliva test. Pt is very pleased with her results and how her general health has improved.
At the 3 month evaluation including a MyPerioProgress® the patient had improved but periodontal concerns still remained. A second round of systemic antibiotic was administered based on the second MyPerioPath® results and a follow-up was scheduled. Following the second MyPerioProgress® - total of three MyPerioPath testsperformed 9 months after therapy, a 61% reduction of the total bacterial load was achieved. The patient is very pleased with her periodontal results and feels the zinc supplements have helped the blood sugar control. We have helped her achieve good periodontal health while helping her decrease health risks. Medically, the patient has seen great improvements. Her blood sugar is now 100-120 and she is working with her medical team to lower or eliminate some of her diabetic medicines. “The saliva testing has given us a great way to add science to the equations and give us quantitative results.”